World's Best Scientists 2026 revealed!
CNS and Neurological Disorders - Drug Targets
H-index 16

CNS and Neurological Disorders - Drug Targets

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Neuroscience 308 28 39 9
Medicine 2104 31 39 12

Additional Metrics

Number of Best Scientists*: 87
Documents by Best Scientists*: 114
Top 100 Ranked Scientists*: 4
SCIMAGO H-index: 101
SCIMAGO SJR: 0.71
Impact Factor: 3

Overview

Top Research Topics at Cns & Neurological Disorders-drug Targets?

The concepts of Neuroscience, Disease, Pharmacology, Neuroprotection and Internal medicine are tackled in Cns & Neurological Disorders-drug Targets. Cns & Neurological Disorders-drug Targets explores topics in Neuroscience which can be helpful for research in disciplines like Receptor, Neurodegeneration and Parkinson's disease. Cns & Neurological Disorders-drug Targets connects research in Parkinson's disease with the related topic of Dopaminergic.

It holds forums on Disease that merges themes from other disciplines such as Immunology, Pathogenesis and Bioinformatics. Immune system, Inflammation and Microglia are all aspects of Immunology discussed in Cns & Neurological Disorders-drug Targets. Cns & Neurological Disorders-drug Targets links adjacent topics like Pharmacology with Oxidative stress.

Most of the works presented in it deals with Internal medicine but it intersects with the subject of Endocrinology.

  • Neuroscience (33.11%)
  • Disease (18.17%)
  • Pharmacology (17.80%)

What are the most cited papers published in the journal?

  • Gliogenesis and glial pathology in depression. (456 citations)
  • Clearance of amyloid-β peptide across the blood-brain barrier: Implication for therapies in Alzheimer’s disease (378 citations)
  • Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities. (331 citations)

Research areas of the most cited articles at Cns & Neurological Disorders-drug Targets:

The published articles generally zeroe in on subjects such as Neuroscience, Pharmacology, Neuroprotection, Immunology and Receptor. The published articles address concerns in Neuroscience which are intertwined with other disciplines, such as Parkinson's disease, Neurodegeneration and Microglia. Alzheimer's disease and Disease are some topics wherein Immunology research discussed in the most cited articles has an impact.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Gene
  • Enzyme

The previous edition focused in particular on these issues:

Cns & Neurological Disorders-drug Targets investigates studies in Disease, Pharmacology, Neuroprotection, Internal medicine and Neuroscience. While the journal focused on Disease, it was also able to explore topics like Multiple sclerosis, Review article and Bioinformatics. Pharmacology research featured in it incorporates concerns from various other topics such as Arachidonic acid, Receptor, Endocannabinoid system, Opioid and Curcuma.

Some problems in Neuroprotection that were presented in the journal overlapped with concepts under Dementia, Ischemia, Brain damage, Programmed cell death and Synaptophysin. The studies on Internal medicine discussed can also contribute to research in the domains of Endocrinology and Memory impairment. In particular, the Neuroscience works presented emphasize discussions on Central nervous system.

The most cited articles from the last journal are:

  • Persons with co-existing neurological disorders: Risk analysis, considerations and management in COVID-19 pandemic. (7 citations)
  • Prospective Role of Polyphenolic Compounds in the Treatment of Neurodegenerative Diseases. (7 citations)
  • Understanding correlation of abnormal c-JNK/p38MAPK signaling in amyotrophic lateral sclerosis: Potential drug targets and influences on neurological disorders. (4 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Cns & Neurological Disorders-drug Targets (based on the number of publications) are:

  • Mohammad Amjad Kamal (95 papers) published 5 papers at the last edition, 1 more than at the previous edition,
  • Oscar Arias-Carrión (62 papers) absent at the last edition,
  • Stephen D. Skaper (59 papers) absent at the last edition,
  • Hari Shanker Sharma (42 papers) absent at the last edition,
  • Aruna Sharma (40 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Cns & Neurological Disorders-drug Targets (based on the number of publications) are:

  • King Abdulaziz University (69 papers) published 3 papers at the last edition, 1 less than at the previous edition,
  • Federal University of Rio de Janeiro (39 papers) published 1 paper at the last edition the same number as at the previous edition,
  • University of Padua (38 papers) absent at the last edition,
  • Uppsala University (29 papers) absent at the last edition,
  • Sapienza University of Rome (22 papers) published 1 paper at the last edition, 2 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 14.16% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 14.43% were posted by at least one author from the top 10 institutions publishing in the journal. Another 4.12% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 23.71% of all publications and 57.73% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities and Prospects in the Field

For those who are intrigued by these intricate Neuroscience and Pharmacology topics, the path of becoming a Speech and Language Pathologist could be a rewarding one. As a Speech and Language Pathologist, one would have the opportunity to work with patients who experience difficulties related to cognitive aspects such as language and speech disorders, which could include neurological disorders mentioned in this article. Pursuing a career in this field would involve hands-on training, theoretical studies, license examination, and continuous education. For individuals who are eager to make a positive impact on people's lives and have an inclination towards Neuroscience and Pharmacology, this profession might be a great fit. Our comprehensive guide on how to be a speech therapist in Vermont offers a precise outline of everything one needs to know about becoming a Speech-Language Pathologist in Vermont. This includes detailed information about educational requirements, certification, license details, and job prospects in Vermont. Just as CNS & Neurological Disorders-drug Targets presents new findings and updates related to Pharmacology and Neuroscience, staying abreast with contemporary researches and trends are also crucial for professionals in this field. So, whether you're a researcher, a student, or a professional looking to advance your career, resources like these can provide valuable insights. The growing relevance and development in Neuroscience and related fields open up numerous opportunities for aspiring professionals and scholars. By opting for a career as a Speech and Language Pathologist, an individual can get a chance to directly apply these concepts and contribute to the healthcare community while aiding patients who struggle with these conditions.

Top Publications

  • The Role of Annexin A1 and Formyl Peptide Receptor 2/3 Signaling in Chronic Corticosterone-Induced Depression-Like behaviors and Impairment in Hippocampal-Dependent Memory.

    Alessio Filippo Peritore;Rosalia Crupi;Maria Scuto;Enrico Gugliandolo

    (2020)
    53 Citations
  • Speech as a Biomarker for Depression.

    (2021)
    53 Citations
  • Inflammation and Mitochondrial Dysfunction in Autism Spectrum Disorder.

    Maria Gevezova;Victoria Sarafian;George Anderson;Michael Maes

    (2020)
    49 Citations
  • When Sick Brain and Hopelessness Meet: Some Aspects of Suicidality in the Neurological Patient

    Alessandra Costanza;Andrea Amerio;Andrea Aguglia;Andrea Escelsior

    (2020)
    40 Citations
  • Cenobamate: A Review of its Pharmacological Properties, Clinical Efficacy and Tolerability Profile in the Treatment of Epilepsy.

    (2022)
    22 Citations
  • Plasma Indoleamine-2,3-Dioxygenase (IDO) is Increased in Drug-Naï ve Major Depressed Patients and Treatment with Sertraline and Ketoprofen Normalizes IDO in Association with Pro-Inflammatory and Immune- Regulatory Cytokines.

    Hussein Kadhem Al-Hakeim;Ahmed Jasim Twayej;Arafat Hussein Al-Dujaili;Michael Maes

    (2020)
    20 Citations
  • Circular RNAs in Alzheimer's Disease: A New Perspective of Diagnostic and Therapeutic Targets.

    (2022)
    18 Citations
  • Neurorestoratology: New Advances in Clinical Therapy.

    (2022)
    16 Citations
  • Microglial Cathepsin B and Porphyromonas gingivalis Gingipains as Potential Therapeutic Targets for Sporadic Alzheimer's Disease

    Hiroshi Nakanishi;Saori Nonaka;Zhou Wu

    (2020)
    16 Citations
  • Rethinking Catatonia: New Insights from the Autism Spectrum

    (2022)
    16 Citations

Related Online Degrees & Career Pathways

For those exploring healthcare careers related to Medicine in the USA, online degree programs offer flexible and accelerated options. Many non-nurses interested in entering nursing fields can benefit from online accelerated BSN programs for non nurses, designed to fast-track their education without compromising quality.

Advancing from RN to BSN is also streamlined with some of the fastest RN to BSN program online options available, allowing working nurses to elevate their qualifications in as little as six months. These programs pave the way to more specialized roles such as nurse practitioners.

Understanding the timeline is crucial—those curious about how long it takes to become a nurse practitioner can explore resources detailing how many years does it take to be a nurse practitioner. Generally, accelerated pathways help candidates enter the workforce faster while maintaining essential clinical expertise.

Salary prospects vary by specialization and location. For example, psychiatric nurse practitioner salary by state shows significant differences across the US, highlighting the importance of researching regional opportunities when planning a career.

Best Scientists Contributing to This Journal

Recently Published Articles